The Basel-based biotechnology company Cellestia has received approval for the first clinical trial on its compound CB-103. The clinical trial will be open to patients…
The Basel-based pharmaceutical company Roche has entered a cooperation agreement with the consultancy firm Accenture. The aim is to develop a data platform that connects…
With its acquisition of Aptuit, the biotechnology company Evotec intends to strengthen its position as a leading provider of drug research and development services. Aptuit,…
More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups By the closing date of…
Each year some 250,000 patients develop a type of cancer because of faulty communication between cells. This malfunction occurs in what is known as the…